Cohort Biomonitoring Study to Evaluate the Biocompatibilty of Resin-based Dental Materials
1 other identifier
interventional
100
1 country
1
Brief Summary
Adult patients who require multiple dental restorations will be included in this study. Urine and saliva samples will be taken for determination of bisphenol A levels at several time points, and for analysis of the estrogenic activity using ERE-CALUX. Also buccal cells will be taken. Next, DNA extraction will be done with a commercial kit. We will determine global alterations in DNA methylation and DNA hydroxymethylation levels using UPLC-MS/MS.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started May 2018
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 17, 2016
CompletedFirst Posted
Study publicly available on registry
August 22, 2016
CompletedStudy Start
First participant enrolled
May 2, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 1, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
November 1, 2025
CompletedJuly 3, 2024
July 1, 2024
7.5 years
August 17, 2016
July 2, 2024
Conditions
Outcome Measures
Primary Outcomes (4)
Urinary bisphenol A levels
1 year
Salivary bisphenol A levels
1 year
%DNA methylation
6 months
%DNA hydroxymethylation
6 months
Study Arms (1)
Patients
EXPERIMENTALPatients who require multiple dental restorations. Teeth will be restored with commercial restorative composites
Interventions
Eligibility Criteria
You may qualify if:
- Caucasian, adults,
You may not qualify if:
- acute or chronic medical condition, presence of oral inflammatory conditions during the previous 2 weeks, chronic disease requiring intake of drugs, exposure to diagnostic X-rays in the previous 2 months, smoking and consumption of alcohol
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Universitaire Ziekenhuizen KU Leuvenlead
- KU Leuvencollaborator
Study Sites (1)
BIOMAT, Department of Oral Health Sciences
Leuven, 3000, Belgium
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- HEALTH SERVICES RESEARCH
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 17, 2016
First Posted
August 22, 2016
Study Start
May 2, 2018
Primary Completion
November 1, 2025
Study Completion
November 1, 2025
Last Updated
July 3, 2024
Record last verified: 2024-07
Data Sharing
- IPD Sharing
- Will not share